Who owns ANAVEX LIFE SCIENCES CORP.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AVXL from SEC Form 13F filings across 165 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 165 institutions disclosed 39.5M shares of ANAVEX LIFE SCIENCES CORP. worth $79.7M — about 0% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
165
13F holders
$79.7M
value, 2026 filers
0%
of shares outstanding (39.5M sh)
15
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AVXL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.1M | $16.5M | 0.0% | 0% | +1.1% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $8.3M | 0.0% | 0% | +1.0% |
| 3 | GMT Capital CorpNEW | 2.7M | $5.5M | 0.3% | 0% | new |
| 4 | FEDERATED HERMES, INC. | 2.6M | $5.2M | 0.0% | 0% | +141.2% |
| 5 | TWO SIGMA INVESTMENTS, LP | 2.3M | $4.7M | 0.0% | 0% | -23.3% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.3M | $4.6M | 0.0% | 0% | -5.5% |
| 7 | STATE STREET CORP | 2.0M | $4.0M | 0.0% | 0% | +1.9% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 898,456 | $1.8M | 0.0% | 0% | -5.3% |
| 9 | Summit Financial, LLC | 889,069 | $1.8M | 0.0% | 0% | -2.2% |
| 10 | GOLDMAN SACHS GROUP INC | 889,066 | $1.8M | 0.0% | 0% | -0.2% |
| 11 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886,987 | $1.8M | 0.0% | 0% | +20.7% |
| 12 | BARCLAYS PLC | 868,259 | $1.8M | 0.0% | 0% | +15.1% |
| 13 | NORTHERN TRUST CORP | 789,290 | $1.6M | 0.0% | 0% | +0.6% |
| 14 | MARSHALL WACE, LLP | 758,238 | $1.5M | 0.0% | 0% | -14.8% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 625,946 | $1.3M | 0.0% | 0% | +0.7% |
| 16 | CITADEL ADVISORS LLC | 548,819 | $1.1M | 0.0% | 0% | +66.8% |
| 17 | Private Advisor Group, LLC | 432,000 | $872,640 | 0.0% | 0% | -14.3% |
| 18 | UBS Group AG | 430,843 | $870,303 | 0.0% | 0% | -30.6% |
| 19 | MORGAN STANLEY | 414,151 | $836,583 | 0.0% | 0% | +112.4% |
| 20 | BANK OF AMERICA CORP /DE/ | 405,033 | $818,167 | 0.0% | 0% | -38.1% |
| 21 | LPL Financial LLC | 357,220 | $721,584 | 0.0% | 0% | -12.0% |
| 22 | STIFEL FINANCIAL CORP | 352,975 | $713,010 | 0.0% | 0% | +6.1% |
| 23 | WELLINGTON MANAGEMENT GROUP LLPNEW | 331,133 | $668,889 | 0.0% | 0% | new |
| 24 | Bank of New York Mellon Corp | 297,437 | $600,824 | 0.0% | 0% | +3.2% |
| 25 | Nuveen, LLC | 226,138 | $456,799 | 0.0% | 0% | +23.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.